Brief: Annovis Bio Announces Update On Recruitment Into Its Phase 2/3 Alzheimer's Study
19/04/2023 12:33
April 19 (Reuters) - Annovis Bio Inc ANVS.N :
* ANNOVIS BIO ANNOUNCES UPDATE ON RECRUITMENT INTO ITS PHASE
2/3
ALZHEIMER'S STUDY AND UPCOMING RESEARCH AND DEVELOPMENT WEBCAST
* ANNOVIS BIO INC - PHASE 2/3 AD STUDY CONTINUES TO MAKE
STEADY
PROGRESS IN PATIENT RECRUITMENT
Source text for Eikon: ID:nPn3SpcCVa
Further company coverage: ANVS.N
Recent news on Annovis Bio
See all newsAnnovis Bio Inc reports results for the quarter ended June 30 - Earnings Summary
Annovis Bio Q2 loss widens as R&D costs rise
Annovis Bio Inc expected to post a loss of 45 cents a share - Earnings Preview
Brief: Annovis Announces Pricing Of $15.0 Million Public Offering Of Common Stock And Accompanying Warrants
U.S. STOCKS ON THE MOVE-Amazon, Northrop Grumman, Brown-Forman